DAPAGLIFLOZIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | DAPAGLIFLOZIN |
| DrugBank ID | DB06292 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 17 |
| DL Predictions (≥0.7) | 12 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| influenza | TxGNN Knowledge Graph | L5 |
| influenza, severe, susceptibility to | TxGNN Knowledge Graph | L5 |
| fascioliasis | TxGNN Knowledge Graph | L5 |
| psoriatic arthritis | TxGNN Knowledge Graph | L5 |
| plasmodium vivax malaria | TxGNN Knowledge Graph | L5 |
| x-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph | L5 |
| hereditary late onset parkinson disease | TxGNN Knowledge Graph | L5 |
| endogenous depression | TxGNN Knowledge Graph | L5 |
| major depressive disorder | TxGNN Knowledge Graph | L5 |
| hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11